Online discussion of drug side effects and discontinuation among breast cancer survivors

Author:

Mao Jun J.123,Chung Annie2,Benton Adrian2,Hill Shawndra4,Ungar Lyle5,Leonard Charles E.2,Hennessy Sean2,Holmes John H.23

Affiliation:

1. Department of Family Medicine and Community Health; Perelman School of Medicine at the University of Pennsylvania; Philadelphia PA, USA

2. Center for Clinical Epidemiology and Biostatistics; Perelman School of Medicine at the University of Pennsylvania; Philadelphia PA, USA

3. Abramson Cancer Center; Perelman School of Medicine at the University of Pennsylvania; Philadelphia PA, USA

4. University of Pennsylvania, The Wharton School; Philadelphia PA, USA

5. University of Pennsylvania School of Engineering and Applied Science; Philadelphia PA, USA

Funder

National Library of Medicine

American Cancer Society

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference36 articles.

1. Miniwatts Marketing Group Internet World Stats: Usage and Population Statistics 2011 http://www.internetworldstats.com/stats.htm

2. Fox S The social life of health information 2009

3. Patient perspectives on health advice posted on Internet discussion boards: a qualitative study;Armstrong;Health Expect,2009

4. Globocan: WHO cancer fact sheet International Agency for Research on Cancer 2008 http://globocan.iarc.fr/factsheets/cancers/breast.asp

5. Primary care for survivors of breast cancer;Burstein;N Engl J Med,2000

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3